fda warning about semaglutide approves Ozempic® (semaglutide) as the only GLP-1 RA to reduce the risk of worsening kidney disease and cardiovascular death in adults with type 2 diabetes and chronic kidney disease FDA Drug Recalls and Warnings:

Under new regulations, Ozempic is no longer available in the UK to be prescribed for weight loss and is now restricted to individuals living with type 2 diabetes

You may be a great match for this program if: You have BMI of 27+ with weight-related conditions or 30+ without You've tried diet and exercise without desired results You prefer virtual healthcare over in-person visits You want convenient home delivery You're comfortable with self-injection after training You're committed to lifestyle changes alongside medication You're in overall good health You're not pregnant or breastfeeding You don't have contraindications to Semaglutide You have realistic weight loss goals During your virtual consultation, we'll review your medical history and determine if you qualify for the program

Some patients report that ginger tea or peppermint tea may provide comfort, though evidence for their anti-nausea effects is limited

Eur J Heart Fail (2019) 21(10):12708